相关实验视频

Updated: May 11, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

用H3K27M变异治疗扩散中线质瘤的新进展

Zhi Yang^1,2, Liang Sun^1,2, Haibin Chen^1,2

¹Department of Neurosurgery, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, 310022, China.

|February 5, 2024

概括

有H3K27M变异的扩散中线结质瘤是一种罕见的儿科脑癌,存活率非常低. 本综述涵盖了针对这种侵袭性瘤的创新治疗方法和研究.

科学领域:

神经瘤学神经瘤学
儿科瘤学儿科瘤学
癌症遗传学癌症遗传学

背景情况:

扩散性中线质瘤,H3K27M改变,是儿童和青少年的一种主要恶性脑瘤.
这种疾病的特点是死亡率极高,新诊断患者的5年生存率为1%.
传统的治疗方法不足,需要新的治疗策略.

研究的目的:

综合审查H3K27M改变的扩散性中线质瘤的创新治疗方法.
提供关于临床前研究和临床试验的最新研究进展的最新信息.
为改善这种侵袭性儿科脑瘤的临床治疗策略做出贡献.

主要方法:

对创新治疗方法的系统文献审查.
临床前研究和临床试验数据的分析.
专注于H3K27M改变的扩散性中线质瘤.

主要成果:

确定新兴的治疗目标和方法.
有希望的临床前发现和正在进行的临床试验的总结.
强调需要新的治疗模式.

结论:

创新的治疗方法对于改善H3K27M改变的扩散性中线质瘤的结果至关重要.
在临床前和临床环境中正在进行的研究表明潜在的.
进一步的研究和新疗法的开发是必不可少的.

关键词:

这就是DIPG.H3K27 M 改变 DMG 的变化 H3K27 M 突变的DMG病毒研究进展的研究进展.治疗疗法治疗疗法

更多相关视频

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...